Gene: SMUG1
Official Full Name: single-strand-selective monofunctional uracil-DNA glycosylase 1provided by HGNC
Gene Summary: This gene encodes a protein that participates in base excision repair by removing uracil from single- and double-stranded DNA. Many alternatively spliced transcript variants exist for this gene; the full-length nature is known for some but not all of the variants. [provided by RefSeq, Aug 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29118 | SMUG1 Knockout cell line (HeLa) | Human | SMUG1 | 1:3~1:6 | Negative | Online Inquiry |
KO29119 | SMUG1 Knockout cell line (HCT 116) | Human | SMUG1 | 1:2~1:4 | Negative | Online Inquiry |
KO29120 | SMUG1 Knockout cell line (HEK293) | Human | SMUG1 | 1:3~1:6 | Negative | Online Inquiry |
KO29121 | SMUG1 Knockout cell line (A549) | Human | SMUG1 | 1:3~1:4 | Negative | Online Inquiry |
SMUG1 Gene Knockout Cell Lines are specialized cellular models engineered to specifically lack the SMUG1 gene, which encodes for a DNA repair enzyme known for its role in base excision repair. These cell lines serve as critical tools for investigating the biological functions of SMUG1, particularly its involvement in maintaining genomic stability and cellular responses to DNA damage. By using the knockout approach, researchers can elucidate the consequences of absent SMUG1 activity, facilitating an understanding of its role in various cellular processes and disease states.
The SMUG1 knockout mechanism operates through the selective disruption of the gene, resulting in a non-functional protein that eliminates its enzymatic activity. This allows scientists to explore the resultant phenotypic changes, including altered DNA repair pathways, increased mutation rates, and cellular susceptibility to genotoxic agents. These alterations are pivotal in understanding not only basic biological processes but also the mechanisms underlying cancer progression and resistance to therapies.
In both research and clinical settings, SMUG1 Gene Knockout Cell Lines have significant implications. They provide a reliable platform for drug discovery, particularly for compounds targeting DNA repair pathways. Additionally, these cell lines allow for the exploration of novel therapeutic strategies aimed at enhancing the efficacy of existing treatments through the potentiation of DNA damage in cancer cells.
One of the primary advantages of our SMUG1 Gene Knockout Cell Lines is their specificity and reliability, which surpass many conventional methods of gene manipulation. Traditional techniques often result in variable expression levels, whereas our knockout lines provide a uniform genetic background that offers reproducibility and precision in experimental outcomes. Furthermore, they are provided with comprehensive characterizations, ensuring users have access to verified functional properties.
For researchers and clinicians focused on genetics, molecular biology, and oncology, the SMUG1 Gene Knockout Cell Lines represent invaluable resources that streamline experiments, enabling insights that could lead to innovative treatments. Our company, with its commitment to advancing scientific knowledge and providing high-quality biological products, stands out as a leading provider of validated knockout models, making us an essential partner in addressing the complexities of modern biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.